An intracellular multiplication F (IcmF) family protein is a conserved component of a newly identified type VI secretion system (T6SS) encoded in many animal and plant-associated Proteobacteria. We have previously identified ImpL M , an IcmF family protein that is required for the secretion of the T6SS substrate hemolysincoregulated protein (Hcp) from the plant-pathogenic bacterium Agrobacterium tumefaciens. In this study, we characterized the topology of ImpL M and the importance of its nucleotide-binding Walker A motif involved in Hcp secretion from A. tumefaciens. A combination of ␤-lactamase-green fluorescent protein fusion and biochemical fractionation analyses revealed that ImpL M is an integral polytopic inner membrane protein comprising three transmembrane domains bordered by an N-terminal domain facing the cytoplasm and a Cterminal domain exposed to the periplasm. impL M mutants with substitutions or deletions in the Walker A motif failed to complement the impL M deletion mutant for Hcp secretion, which provided evidence that ImpL M may bind and/or hydrolyze nucleoside triphosphates to mediate T6SS machine assembly and/or substrate secretion.
Many pathogenic gram-negative bacteria employ protein secretion systems formed by macromolecular complexes to deliver proteins or protein-DNA complexes across the bacterial membrane. In addition to the general secretory (Sec) pathway (18, 52) and twin-arginine translocation (Tat) pathway (7, 34) , which transport proteins across the inner membrane into the periplasm, at least six distinct protein secretion systems occur in gram-negative bacteria (28, 46, 66) . These systems are able to secrete proteins from the cytoplasm or periplasm to the external environment or the host cell and include the welldocumented type I to type V secretion systems (T1SS to T5SS) (10, 15, 23, 26, 30) and a recently discovered type VI secretion system (T6SS) (4, 8, 22, 41, 48, 49) . These systems use ATPase or a proton motive force to energize assembly of the protein secretion machinery and/or substrate translocation (2, 6, 41, 44, 60) .
Agrobacterium tumefaciens is a soilborne pathogenic gramnegative bacterium that causes crown gall disease in a wide range of plants. Using an archetypal T4SS (9) , A. tumefaciens translocates oncogenic transferred DNA and effector proteins to the host and ultimately integrates transferred DNA into the host genome. Because of its unique interkingdom DNA transfer, this bacterium has been extensively studied and used to transform foreign DNA into plants and fungi (11, 24, 40, 67) . In addition to the T4SS, A. tumefaciens encodes several other secretion systems, including the Sec pathway, the Tat pathway, T1SS, T5SS, and the recently identified T6SS (72) . T6SS is highly conserved and widely distributed in animal-and plantassociated Proteobacteria and plays an important role in the virulence of several human and animal pathogens (14, 19, 41, 48, 56, 63, 74) . However, T6SS seems to play only a minor role or even a negative role in infection or virulence of the plant-associated pathogens or symbionts studied to date (5, (37) (38) (39) 72) .
T6SS was initially designated IAHP (IcmF-associated homologous protein) clusters (13) . Before T6SS was documented by Pukatzki et al. in Vibrio cholerae (48) , mutations in this gene cluster in the plant symbiont Rhizobium leguminosarum (5) and the fish pathogen Edwardsiella tarda (51) caused defects in protein secretion. In V. cholerae, T6SS was responsible for the loss of cytotoxicity for amoebae and for secretion of two proteins lacking a signal peptide, hemolysin-coregulated protein (Hcp) and valine-glycine repeat protein (VgrG). Secretion of Hcp is the hallmark of T6SS. Interestingly, mutation of hcp blocks the secretion of VgrG proteins (VgrG-1, VgrG-2, and VgrG-3), and, conversely, vgrG-1 and vgrG-2 are both required for secretion of the Hcp and VgrG proteins from V. cholerae (47, 48) . Similarly, a requirement of Hcp for VgrG secretion and a requirement of VgrG for Hcp secretion have also been shown for E. tarda (74) . Because Hcp forms a hexameric ring (41) stacked in a tube-like structure in vitro (3, 35) and VgrG has a predicted trimeric phage tail spike-like structure similar to that of the T4 phage gp5-gp27 complex (47) , Hcp and VgrG have been postulated to form an extracellular translocon. This model is further supported by two recent crystallography studies showing that Hcp, VgrG, and a T4 phage gp25-like protein resembled membrane penetration tails of bacteriophages (35, 45) .
Little is known about the topology and structure of T6SS machinery subunits and the distinction between genes encoding machinery subunits and genes encoding regulatory proteins. Posttranslational regulation via the phosphorylation of Fha1 by a serine-threonine kinase (PpkA) is required for Hcp secretion from Pseudomonas aeruginosa (42) . Genetic evidence for P. aeruginosa suggested that the T6SS may utilize a ClpVlike AAA ϩ ATPase to provide the energy for machinery assembly or substrate translocation (41) . A recent study of V. cholerae suggested that ClpV ATPase activity is responsible for remodeling the VipA/VipB tubules which are crucial for type VI substrate secretion (6) . An outer membrane lipoprotein, SciN, is an essential T6SS component for mediating Hcp secretion from enteroaggregative Escherichia coli (1) . A systematic study of the T6SS machinery in E. tarda revealed that 13 of 16 genes in the evp gene cluster are essential for secretion of T6S substrates (74) , which suggests the core components of the T6SS. Interestingly, most of the core components conserved in T6SS are predicted soluble proteins without recognizable signal peptide and transmembrane (TM) domains.
The intracellular multiplication F (IcmF) and H (IcmH) proteins are among the few core components with obvious TM domains (8) . In Legionella pneumophila Dot/Icm T4SSb, IcmF and IcmH are both membrane localized and partially required for L. pneumophila replication in macrophages (58, 70, 75) . IcmF and IcmH are thought to interact with each other in stabilizing the T4SS complex in L. pneumophila (58) . In T6SS, IcmF is one of the essential components required for secretion of Hcp from several animal pathogens, including V. cholerae (48) , Aeromonas hydrophila (63) , E. tarda (74) , and P. aeruginosa (41) , as well as the plant pathogens A. tumefaciens (72) and Pectobacterium atrosepticum (39) . In E. tarda, IcmF (EvpO) interacted with IcmH (EvpN), EvpL, and EvpA in a yeast two-hybrid assay, and its putative nucleotide-binding site (Walker A motif) was not essential for secretion of T6SS substrates (74) .
In this study, we characterized the topology and interactions of the IcmF and IcmH family proteins ImpL M and ImpK L , which are two essential components of the T6SS of A. tumefaciens. We adapted the nomenclature proposed by Cascales (8) , using the annotated gene designation followed by the letter indicated by Shalom et al. (59) . Our data indicate that ImpL M and ImpK L are both integral inner membrane proteins and interact with each other via their N-terminal domains residing in the cytoplasm. We also provide genetic evidence showing that ImpL M may function as a nucleoside triphosphate (NTP)-binding protein or nucleoside triphosphatase to mediate T6S machinery assembly and/or substrate secretion.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Strains, plasmids, and primer sequences used in this study are listed in Table 1 and Table 2 . For Hcp secretion assays, A. tumefaciens cells grown overnight in 523 broth (31) with appropriate antibiotics were harvested by centrifugation (8,000 ϫ g, 10 min) and resuspended in AB-MES medium (pH 5.5) (33) without any antibiotics at an optical density at 600 nm (OD 600 ) of ϳ0.1. After growth for 6 h at 25°C, the cells were harvested, and proteins secreted into the culture medium were precipitated with trichloroacetic acid as described previously (72) . The plasmids were maintained by addition of 250 g/ml carbenicillin, 50 g/ml gentamicin, and 200 g/ml spectinomycin for A. tumefaciens and by addition of 100 g/ml ampicillin, 100 g/ml spectinomycin, 20 g/ml kanamycin, and 50 g/ml gentamicin for E. coli. Plasmid pJQ200KS-⌬impK L or pJQ200KS-⌬impL M was transformed into A. tumefaciens C58 via electroporation and selected on sucrose-free 523 agar containing gentamicin at 28°C for 2 days for the first recombination events. Positive colonies were confirmed by PCR and were grown further in sucrose-free 523 broth without antibiotics at 28°C overnight. Serial dilutions (up to 10 Ϫ4 ) were plated onto 523 agar containing 5% sucrose without antibiotics and grown at 28°C for 2 days to select for colonies with a second recombination event. Sucroseresistant, gentamicin-sensitive colonies were confirmed by PCR to obtain the ⌬impL M and ⌬impK L deletion mutants. For complementation, plasmid pImpK L was constructed in the same way as pImpL M (or pIcmF), in which impL M (or icmF) was driven by a lac promoter in the broad-host-range vector pRL662. The impK L ORF and the corresponding ribosomal binding sequences were amplified with primers 22 and 23, and the PCR product was digested with XhoI/XbaI and cloned into the same sites of pRL662, resulting in plasmid pImpK L .
Topology analysis using ␤-lactamase (BlaM) and green fluorescent protein (GFP) fusions. To generate ␤-lactamase fusions in pImpL M by transposon mutagenesis, an EZ-Tn5 transposon assay was carried out according to the manufacturer's instructions using an EZ-Tn5 ␤-lactamase fusion kit (Epicentre Biotechnologies, Madison, WI). Fusions were also created by cloning. Plasmid pBlaM was generated to express BlaM without a signal peptide by ligating a PCR fragment amplified from a plasmid containing the EZ-Tn5 transposon into the HindIII site of pRL662. Plasmid pTM1-BlaM-TM2ϩ3 was generated by ligating XhoI/KpnI-digested impL M PCR product 1 (primers 17 41 ) and the KpnI/XbaI-digested gfp ORF (primers 31 and 35) into the XhoI/XbaI sites of pRL662. ␤-Lactamase activity was examined by determining the ability of E. coli strains to grow on LB medium with 100 g/ml ampicillin at 37°C overnight or the ability of A. tumefaciens strains to grow on 523 medium with 250 g/ml carbenicillin at 28°C for 24 h.
Generating mutations in the Walker A motif of ImpL M by site-directed mutagenesis. Mutations in the Walker A motif of ImpL M were created by sitedirected mutagenesis as described previously (27) . For plasmid pImpL M K145A , two complementary PCR products encoding replacement of lysine 145 by alanine flanked by 10 to 15 bases of overlapping sequence were amplified separately using two pairs of primers (primers 15 and 9 and primers 16 and 17). For plasmid pImpL M G144A K145A , two complementary PCR products encoding replacement of double mutations at glycine 144 and lysine 145 with two alanines were amplified using primers 18 and 9 and primers 19 and 17. For plasmid pImpL M ⌬Walker A , two complementary PCR products with deletion of the Walker A motif were amplified using primers 20 and 9 and primers 21 and 17. The two PCR products were combined and amplified using primers 9 and 17, resulting in a 1.5-kb DNA fragment. The DNA fragment was further digested with XhoI/BamHI and ligated at the same sites in pImpL M to create the K145A, G144A K145A, and ⌬Walker A mutations in pImpL M .
Yeast two-hybrid assay. The Matchmaker yeast two-hybrid system was used according to the instructions described in the user's manual (Clontech, Mountain View, CA). The impL M ORF PCR amplified with primers 7 and 2 or primers 7 and 8 was digested with NdeI/XhoI or NdeI/SmaI and cloned into the NdeI/XhoI sites of pGADT7 for N-terminal fusion to the activation domain (AD) or into the NdeI/SmaI sites of pGBKT7 for N-terminal fusion to the DNA-binding domain (BD), resulting in pAD-ImpL M and pBD-ImpL M , respectively. For plasmids pAD-N-ImpL M and pBD-N-ImpL M , a PCR fragment encoding the N terminus of ImpL M (amino acids 1 to 495) was amplified using primers 7 and 9, and the NdeI/BamHI-digested PCR product was cloned into the NdeI/BamHI sites of pGADT7 and pGBKT7. For plasmids pAD-C-ImpL M and pBD-C-ImpL M , a PCR fragment encoding the C terminus of ImpL M (amino acids 466 to 1159) was amplified using primers 1 and 2 or primers 1 and 10 and digested with NdeI/XhoI or NdeI/PstI before ligation into the NdeI/XhoI and NdeI/PstI sites of pGADT7 and pBGKT7, respectively. For plasmids pAD-ImpK L and pBD-ImpK L , the impK L ORF was PCR amplified using primers 11 and 12, digested with NdeI/ BamHI, and cloned into the same sites of pGADT7 and pGBKT7. For plasmids pAD-N-ImpK L and pBD-N-ImpK L , a PCR fragment encoding the N terminus of ImpK L (amino acids 1 to 255) was amplified using primers 11 and 13, digested with NdeI/BamHI, and cloned into the same sites of both pGADT7 and pGBKT7. For pAD-C-ImpK L and pBD-C-ImpK L , a PCR fragment encoding the C terminus of ImpK L (amino acids 279 to 501) was amplified using primers 14 and 12, digested with NdeI/BamHI, and cloned into the same sites of pGADT7 and pGBKT7.
The resulting prey and bait plasmids were used to cotransform Saccharomyces cerevisiae strain AH109. The transformants were selected on the basis of their growth on synthetic dextrose (SD) minimal medium lacking tryptophan (Trp) and leucine (Leu). Positive interactions of expressed fusion proteins were then determined by growth on SD medium lacking Trp, Leu, adenine, and histidine (His) at 30°C for 3 days.
Biochemical fractionation. A. tumefaciens cellular fractions were isolated as described previously (16) , with minor modifications. Cells were harvested and resuspended in osmotic shock buffer (50 mM Tris-Cl, 20% sucrose, 2 mM EDTA, 0.5 mg/ml lysozyme, 1 mM phenylmethylsulfonyl fluoride [PMSF]; pH 7.5) to an OD 600 of 5. After incubation at room temperature for 1 h, the cells whose lysates are referred to below as total protein were centrifuged twice at 10,000 ϫ g at 4°C to obtain a supernatant solution containing the periplasmic proteins. The resulting pellet, resuspended in the same volume of sonication buffer (50 mM Tris-HCl [pH 7.5], 0.2 M KCl, 1 mM PMSF), was subjected to cell lysis via sonication and then centrifugation twice at 10,000 ϫ g at 4°C. The supernatant solution containing both the cytoplasmic and membrane proteins was then centrifuged at 150,000 ϫ g for 1 h at 4°C to obtain the cytosolic proteins (supernatant) and membrane proteins (pellet). For protein solubilization studies, the membrane fractions were resuspended (final protein concentration, 1 mg/ml) by sonication in 50 mM Tris-HCl (pH 7.5) containing 1 mM PMSF and incubated on ice for 30 min with or without one of the following compounds: 1 M NaCl, 0.1% Na 2 CO 3 , 6 M urea, 3% Triton X-100, 1.5% N-lauroylsarcosine, or 1% sodium dodecyl sulfate (SDS). Each reaction mixture was centrifuged at 150,000 ϫ g for 1 h at 4°C. The resulting supernatant solution and the pellet, resuspended in an equivalent volume of 50 mM Tris-HCl (pH 7.5), were analyzed by immunoblotting. To separate the inner and outer membranes by sucrose density gradient centrifugation, cells were harvested and resuspended in lysis buffer (50 mM Tris-HCl [pH 7.5], 20% sucrose, 0.2 M KCl, 0.2 mM dithiothreitol, 0.2 mg/ml RNase A, 0.2 mg/ml DNase, 1 mM PMSF) to an OD 600 of 10. The cells were lysed by two passages through a French pressure cell (Aminco, Silver Spring, MD) at 16,000 lb/in 2 , followed by lysozyme (0.5 mg/ml) treatment on ice for 30 min. The cell lysate was centrifuged at 20,000 ϫ g at 4°C for 15 min, and the supernatant solution was then centrifuged at 150,000 ϫ g for 1 h at 4°C. The pellet, enriched with inner and outer membrane proteins, was resuspended in 2.5 ml of buffer containing 20% sucrose, 0.2 mM dithiothreitol, and 5 mM EDTA by sonication on ice. Two milliliters of membrane proteins was layered onto an EDTA (5 mM)-sucrose gradient containing 6 ml of 53% sucrose on top of 2 ml of 70% sucrose, and this was followed by centrifugation at 150,000 ϫ g for 16 h at 4°C. One-milliliter fractions were collected from the top of the gradient and analyzed by immunoblotting. The quality of fractionation was assessed by measuring the absorption at 280 nm of fractions, the enzymatic activity of the inner membrane marker NADH oxidase (16, 43) , and the density of the fractions. Plasmid pET-C-ImpL M -His was constructed by ligating a PCR fragment encoding the C terminus of ImpL M (amino acids 466 to 1159), amplified using primers 1 and 2 to overexpress the C terminus of ImpL M , in E. coli BL21(DE3). The procedure used for protein purification was described previously (72) . The major 66-kDa protein band, corresponding to the putative C terminus of ImpL M -His, was cut out from an SDS gel and used to generate polyclonal antibodies in rabbits. Immunoblot analysis was performed as described previously (33) using primary polyclonal antibodies against C-ImpL M , Hcp (72), ActC (36), or His 6 (LTK BioLaboratories, Taipei, Taiwan) followed by a secondary antibody using horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (chemichem), and the results were detected using the Western Lightning system (Perkin Elmer, Boston, MA). Chemiluminescent bands were visualized using X-ray film (Kodak, Rochester, NY).
Copurification of ImpK L -His and ImpL M . Plasmid pET-ImpK L -His used for copurification was created by PCR amplifying the impK L ORF using primers 3 and 4, and the NdeI/XhoI-digested PCR product was cloned into the NdeI/XhoI sites of pET22b(ϩ). Plasmid pTrc-ImpL M used for copurification was created by PCR amplifying the impL M ORF using primers 5 and 6, and the KpnI/HindIIIdigested PCR product was cloned into the KpnI/HindIII sites of pTrc200.
An overnight culture of E. coli BL21(DE3) cells harboring pET-ImpK L -His and pTrc-ImpL M was subcultured at a 1:100 dilution into fresh LB medium and grown to an OD 600 of 0.4 to 0.6. Isopropyl-␤-D-thiogalactopyranoside (IPTG) was added to a final concentration of 0.4 mM, and the cells were incubated at 28°C for 2 h. The harvested cells were resuspended in lysis buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 10 mM imidazole, 1 mM PMSF; pH 8.0) and subjected to sonication on ice. The cell lysate was centrifuged at 20,000 ϫ g for 15 min at 4°C. The soluble fraction was loaded onto an Ni 2ϩ -nitrilotriacetic acid (NTA) column (Novagen) and washed with washing buffer (50 mM NaH 2 PO 4 , 0.3 M NaCl, 50 mM imidazole; pH 8.0), and the bound proteins were eluted with elution buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 250 mM imidazole; pH 8.0). The fractions were analyzed by immunoblotting.
RESULTS
ImpL M is tightly associated with the inner membrane. IcmF is a conserved component that is essential for T6SS-mediated Hcp secretion. However, there is little biochemical evidence that can be used to understand its function, except the prediction that it is an inner membrane protein containing a Walker A nucleotide-binding motif (8) . A. tumefaciens produces an IcmF family protein, ImpL M , that is essential for Hcp secretion from A. tumefaciens (72) . We first examined the subcellular localization and biochemical properties of ImpL M by performing fractionation and protein solubilization assays, followed by immunoblot analysis. ImpL M was detected exclusively in the membrane fraction of A. tumefaciens wild-type virulent strain C58. A citrate transporter, ActC (36), served as a soluble protein marker in the periplasmic and cytosolic fractions (Fig.  1A) . Ultracentrifugation through sucrose density gradients was used to separate inner and outer membrane fractions and to determine the membrane localization of ImpL M . Most ImpL M was present in the inner membrane fractions (Fig. 1B) , suggesting that ImpL M is localized to the inner membrane.
We attempted to solubilize ImpL M by incubating the membrane fractions of A. tumefaciens C58 with various chemicals. ImpL M was not solubilized by high salt (1 M NaCl) or by basic buffer (0.1% Na 2 CO 3 ), but it was slightly solubilized by 6 M urea (Fig. 1C) , suggesting that it is tightly associated with membranes. The partial solubilization of ImpL M by the nonionic detergent Triton X-100 at a concentration of 3% and the complete solubilization of ImpL M by the strong ionic detergents SDS and N-lauroylsarcosine (Fig. 1C) indicated that this protein is associated with membranes mainly via hydrophobic interactions. The biochemical fractionation and solubilization data coincided with the predicted features of ImpL M as an integral inner membrane protein; this prediction was further confirmed as follows.
ImpL M is a polytopic integral inner membrane protein with the N terminus facing the cytoplasm and the C terminus exposed to the periplasmic space. ImpL M is a 128-kDa protein which is predicted to be localized to the inner membrane with three TM domains and a Walker A motif located between the second and third TM domains (Fig. 2A) . To investigate further the biochemical functions of ImpL M , it is important to validate its membrane topology. We previously demonstrated that trans expression of impL M from plasmid pImpL M (previously designated pIcmF) in a ⌬impL M mutant could restore Hcp secretion from the virulent strain A. tumefaciens NT1RE(pJK270) (72) . In this study, the loss of Hcp secretion from the ⌬impL M in-frame deletion mutant created with A. tumefaciens C58 was restored in the presence of pImpL M (Fig. 2B) . To determine the topology of ImpL M , we used transposon EZ-Tn5 randomly to insert a gene encoding ␤-lactamase (BlaM) into pImpL M to generate various EZ-Tn5 transposon-mutagenized plasmids which may produce ImpL M -BlaM fusion proteins. BlaM serves as a periplasmic reporter by conferring resistance to ampicillin or carbenicillin because it is active only after translocation to the periplasm (68) . EZ-Tn5-mutagenized plasmids were first transformed into E. coli DH10B to select Ap r colonies, following which resistance to carbenicillin was confirmed for the A. tumefaciens ⌬impL M mutant. We obtained seven independent Cb r clones, which resulted in four different insertion sites. Sequence analysis revealed that BlaM was inserted into the C-terminal domain of ImpL M in all four plasmids at positions 1 to 4 ( Fig. 2A) , which suggested that the C terminus of ImpL M is localized to the periplasm. (Fig. 2C) .
If the ImpL M C-terminal domain is localized to the periplasm, one can propose that the N terminus is localized in the cytosol with three TM domains integrated in the inner membrane (Fig. 2C) . To validate this topology, we first created the pImpL M -BlaM-end construct, in which BlaM lacking a signal peptide is fused to the C terminus of ImpL M . The ability of pImpL M -BlaM-end to confer Ap r or Cb r when it was expressed in E. coli or A. tumefaciens indicated that the entire C-terminal domain was located in the periplasm. Next, we created constructs in which BlaM was fused internally in the region between the first and second TM domains (position 6 for pTM1-BlaM-TM2ϩ3 [ Fig. 2A and 2C] ) and in the region between the second and third TM domains (position 7 for pTM1ϩ2-BlaM-TM3 and position 8 for pTM1ϩ2-BlaM [ Fig.  2A and 2C] ). pTM1-BlaM-TM2ϩ3, but not pTM1ϩ2-BlaM-TM3 or pTM1ϩ2-BlaM, was able to confer Ap r or Cb r when it was expressed in E. coli or A. tumefaciens, suggesting that the region between TM1 and TM2 is located in the periplasm (Fig.  2C) . The inability of pTM1ϩ2-BlaM-TM3 to confer Cb r did not result from instability of the fusion protein because we were able to detect expression of this protein at levels comparable to those of other proteins by immunoblotting (Fig. 2B) . None of the BlaM fusion proteins were able to complement the loss of Hcp secretion in the ⌬impL M strain (Fig. 2B) , suggesting that the sequences between TM1/TM2, TM2/TM3, and the C-terminal domain of ImpL M , as well as the size and distance between these domains, are important for retaining the function of ImpL M in mediation of Hcp secretion.
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analysis was further confirmed using GFP as a cytoplasmic reporter. GFP folds correctly and is fluorescent in the cytoplasm, but it does not fold into an active form when it is targeted to the periplasm by the Sec general secretory pathway (18, 52) . GFP signals were detected in E. coli or A. tumefaciens when GFP was fused to the N terminus of ImpL M (pGFPImpL M ) or fused after the second TM domain (pTM1ϩ2-GFP; the same position as pTM1ϩ2-BlaM, position 8 [ Fig. 2A and 2C]) (data not shown). However, no GFP signal was detected when GFP was fused to the C terminus of ImpL M (pImpL M -GFP) or inserted into the region between the first and second TM domains (pTM1-GFP-TM2ϩ3; the same position as pTM1-BlaM-TM2ϩ3, position 6). Thus, ImpL M is a polytopic integral inner membrane protein with the N terminus facing the cytoplasmic side and the C terminus exposed to the periplasmic space.
The Walker A motif of ImpL M is required for Hcp secretion. Amino acid sequence alignment of ImpL M and its orthologs in several T6SS as well as T4SSb revealed a highly conserved Walker A motif (Fig. 3A) , suggesting that ImpL M and its orthologs may function as nucleotide-binding proteins and nucleoside triphosphatases. The Walker A motif of ImpL M is located between amino acid residues 139 and 146. Two conserved glycines are separated by 4 amino acids and followed by a conserved lysine and threonine/serine (GXXXXGKT/S). The conserved lysine typically binds the ␤ and ␥ phosphoryl groups of ATP or GTP (71) and is required for full ATPase activity in many traffic ATPases (64) .
To investigate the importance of the Walker A motif of ImpL M in Hcp secretion from A. tumefaciens, we generated mutants by site-directed mutagenesis using a single point mutation in the Walker A motif that replaced Lys with Ala (K145A), using double , and pImpL M ⌬Walker A ) were tested to determine their abilities to complement Hcp secretion from the Agrobacterium ⌬impL M mutant strain. Despite the fact that there was no significant difference in the level of intracellular Hcp among the mutants and the wild-type bacteria, the level of Hcp secreted into the culture medium was significantly lower for the K145A mutant than for wild-type cells (Fig. 3B) . The double and secreted (S) proteins isolated from wild-type, ⌬impL M , and various ImpL M -complemented strains grown in AB-MES (pH 5.5) for 6 h at 25°C were resolved by 12% glycine-SDS-PAGE. BlaM fusion proteins were analyzed to determine their expression and function in Hcp secretion by immunoblot analysis with C-ImpL M , Hcp, and ActC antibodies. The secreted proteins were collected from 1 ml of culture medium after removal of bacterial cells and were concentrated by trichloroacetic acid precipitation and analyzed as described previously (72) . The nonsecreted soluble protein ActC served as an internal control. (C) A. tumefaciens ⌬impL M strains containing either the vector (pRL662) or one of the complementing plasmids containing BlaM fusions were grown in 523 medium with 250 g/ml carbenicillin at 28°C for 24 h to examine their resistance to carbenicillin. The membrane topology of ImpL M is based on the BlaM and GFP fusion results. The positions of molecular mass markers (in kDa) are indicated to the left of the blots. IM, inner membrane; OM, outer membrane. mutation or deletion of the Walker A motif eliminated secretion of Hcp (Fig. 3B) . The reduction and lack of Hcp secretion from the K145A and G144A K145A mutants, respectively, did not result from instability of the mutant proteins because the ImpL M protein levels in the ⌬impL M strains complemented with pImpL M K145A and pImpL M G144A K145A were similar to that in the ⌬impL M strain complemented with pImpL M (Fig. 3B ). In contrast, we were unable to detect any ImpL M upon complementation with pImpL M ⌬Walker A , suggesting that an intact Walker A motif is important for the stability of ImpL M proteins. Taken together, these data provide genetic evidence that the Walker A motif of an IcmF family protein is important in T6SS-mediated Hcp secretion and that ImpL M may bind and/or hydrolyze NTP necessary for T6SS machinery assembly and/or substrate secretion.
ImpL M interacts with another essential T6SS component, ImpK L . It is conceivable that ImpL M could interact with other T6SS components to assemble a functional secretory apparatus. We therefore investigated whether ImpL M interacts with another putative T6SS component, ImpK L , which is a predicted inner membrane protein containing a C-terminal OmpA-like domain. An interaction between these two proteins was suggested by a yeast two-hybrid analysis of E. tarda T6SS (74) and genetic evidence for L. pneumophila T4SSb (58) . We first determined whether ImpK L is required for Hcp secretion from A. tumefaciens. Indeed, Hcp was expressed by but not secreted into culture medium from the ⌬impK L mutant (Fig. 4A) . trans expression of impK L in the ⌬impK L mutant could restore the level of Hcp secretion to wild-type levels (Fig. 4A) , indicating that ImpK L is a T6SS component essential for mediation of Hcp secretion. Interestingly, in the ⌬impK L mutant the level of full-length ImpL M was significantly reduced, along with accumulation of a ϳ55-kDa truncated form. The truncated ImpL M contains at least part of the periplasmic C-terminal domain since this is the domain used to generate antibody for immunoblot analysis of ImpL M . The instability of ImpL M was corrected by trans expression of impK L in the ⌬impK L mutant (Fig. 4A) , suggesting that that there is an interaction between ImpL M and ImpK L because the loss of one protein by a mutation affecting the stability of another protein is a common trait of proteins that interact (21, 25) . ImpK L may function as an essential T6SS component or may play only an accessory role to stabilize ImpL M in mediating Hcp secretion. We therefore tested whether the deficiency in Hcp secretion from the ⌬impK L mutant could be restored by overexpressing ImpL M in the ⌬impK L mutant. As shown in Fig.  4A , no Hcp was detected in the culture medium when ImpL M was overexpressed in the ⌬impK L mutant, suggesting that ImpK L plays a role in T6SS-mediated Hcp secretion in addition to its function in stabilizing ImpL M .
To determine whether ImpL M interacts directly with ImpK L , we first performed a yeast two-hybrid assay using full-length ImpL M and ImpK L fused with the GAL4 AD and BD, respectively. Whereas no cell growth could be detected when each of the fusion proteins was expressed alone with the paired empty vector (see Table S1 in the supplemental material), we are able to detect an interaction between ImpL M and ImpK L (Fig. 5A) . To investigate further the interaction between ImpL M and ImpK L , we engineered E. coli to coexpress ImpK L -His and ImpL M and used an Ni-NTA column to purify ImpK L -His and the interaction proteins. ImpL M coeluted with ImpK L -His from the column, and its level was comparable to that of purified ImpK L -His (Fig. 5B) . In contrast, only a trace amount of ImpL M was eluted from the Ni column by imidazole when ImpL M was expressed alone (Fig. 5C ), suggesting that ImpL M copurified with ImpK L -His due to their physical interaction. Together, these data strongly suggest that ImpL M interacts directly with ImpK L . ImpK L is a bitopic integral inner membrane protein with its N terminus localized in the cytoplasm and its C terminus exposed to the periplasmic space. Our yeast two-hybrid and copurification data suggested that there is an interaction between ImpL M and ImpK L, which led us to characterize further the subcellular localization, topology, and biochemical properties of ImpK L . ImpK L , a 55-kDa protein (501 amino acids), contains one putative TM domain and a carboxyl-terminal domain homologous to the peptidoglycan-binding motif of OmpA from E. coli. We determined ImpK L topology by creating constructs to express a BlaM protein fused with the N or C terminus of ImpK L and examined the resistance to carbenicillin in A. tumefaciens. The ⌬impK L strain complemented with pImpK L -BlaM but not with pBlaM-ImpK L could grow on 523 medium containing carbenicillin (Fig. 4B) , suggesting that the C terminus of ImpK L is exposed to the periplasm and its N terminus is localized in the cytoplasm. This suggested topology was further confirmed using GFP as a cytoplasmic reporter as described above. A GFP signal was detected in the ⌬impK L strain expressing GFP-ImpK L but not in the ⌬impK L strain containing ImpK L -GFP (data not shown). These data suggest that ImpK L is localized to the inner membrane, with its N terminus facing the cytoplasm and its C terminus exposed to the periplasmic space.
FIG. 4.
Immunoblotting and ImpK L topology analyses with ␤-lactamase fusions. (A) Total (T) and secreted (S) proteins isolated from wild-type C58, ⌬impK L , and ⌬impK L strains harboring either the vector or a plasmid expressing wild-type ImpK L , ImpL M , or various fusions were resolved by 12% glycine-SDS-PAGE and analyzed to determine Hcp secretion. Ten percent glycine-SDS-PAGE was employed to examine both full-length and truncated C-ImpL M (indicated by arrowheads) by immunoblotting with C-ImpL M antibody. (B) ⌬impK L mutant strains harboring the vector or plasmids expressing only BlaM, BlaM-ImpK L , or ImpK L -BlaM were streaked on 523 medium containing 200 g/ml carbenicillin and incubated at 28°C for 24 h to examine their resistance to carbenicillin. The membrane topology of ImpK L is based on the BlaM and GFP fusion results. Total (T) and secreted (S) proteins isolated from wild-type strain C58 or ⌬impK L strains containing various ImpK L proteins fused with BlaM or GFP grown in AB-MES (pH 5.5) for 6 h at 25°C were resolved by 12% glycine-SDS-PAGE and analyzed to determine Hcp secretion by immunoblotting. The positions of molecular mass markers (in kDa) are indicated on the left. IM, inner membrane; OM, outer membrane.
We next examined whether the ImpL M protein level in the ⌬impK L strain is increased by complementation with BlaM or GFP fusion proteins. Figure 4A shows that the ImpL M protein level was restored by complementation with a BlaM or GFP fusion. Furthermore, Hcp secretion was also restored for all complemented strains (Fig. 4B) , suggesting that ImpK L fused with BlaM or GFP at either the N or C terminus retains its functionality for stabilizing ImpL M and mediating Hcp secretion.
To investigate further the subcellular localization and biochemical properties of ImpK L , we constructed pImpK L -His to express His-tagged ImpK L in the ⌬impK L strain. ImpK L -His was fully functional for complementing Hcp secretion from ⌬impK L. (Fig. 6A) . Similar to ImpL M, ImpK L was localized in the membrane fraction (Fig. 6B) . Further sucrose density gradient analysis revealed that most ImpK L cofractionated with ImpL M in the inner membrane fractions (Fig. 6C) . Protein solubilization analysis indicated that both ImpK L -His and ImpL M are tightly associated with membranes, mainly via hydrophobic interactions, because they are significantly solubilized only by detergents (Fig. 6D) . Thus, our data suggest that ImpK L is a bitopic integral inner membrane protein with the N terminus exposed to the cytoplasm and the C terminus localized in the periplasm.
DISCUSSION
In this study, we show that ImpL M and ImpK L interact with each other and are both integral inner membrane proteins essential for Hcp secretion from A. tumefaciens. We also provide genetic evidence that the Walker A motif of the IcmF family protein ImpL M is essential for its function in Hcp secretion, suggesting the importance of its NTP-binding and hydrolysis activities in T6SS machinery assembly and/or substrate secretion.
Our topology and biochemical fractionation analyses indicated that ImpL M and ImpK L are both tightly embedded in the inner membrane. Topology analysis with BlaM and GFP fusions suggested that ImpL M consists of three TM domains bordered by an N-terminal domain facing the cytoplasm and a C-terminal domain exposed to the periplasm and that ImpK L contains one TM domain with the N terminus facing the cytoplasm and the C terminus exposed to the periplasmic space ( Fig. 2 and Fig. 4) . The same topological results for the fusion proteins expressed in E. coli or A. tumefaciens suggested that the translocation of these proteins into the inner membrane does not require the assistance of other T6SS components but instead depends on a conserved secretion pathway, such as the Sec pathway (18, 52) . Despite the fact that ImpL M and ImpK L are essentially integral inner membrane proteins, small amounts of them were detected in the outer membrane fraction, where low levels of the inner membrane protein marker NADH oxidase was detected ( Fig. 1 and Fig. 6 ). It seems inevitable that trace amounts of inner membrane proteins are retained in outer membrane fractions because the use of similar techniques with many gram-negative bacteria, including A. tumefaciens, resulted in the same observations (17, 20, 61, 65) . These results may be caused by the presence of several multiprotein complexes spanning both the inner and outer membranes to form protein channels for substrate translocation. However, we do not exclude the possibility that a small portion of ImpK L and/or ImpL M may associate with the outer membrane in a stable or dynamic manner. Because ImpK L possesses a C-terminal periplasmic OmpA-like domain, which contains a peptidoglycan-binding motif, it is possible that the ImpL M -ImpK L interaction complex or ImpK L alone may be linked to the outer membrane via its interactions with the cell wall.
We also obtained strong evidence, by using the yeast twohybrid assay and copurification from E. coli, of the physical interaction between ImpL M and ImpK L ( Fig. 5 ; see Table S1 in the supplemental material). This interaction was also supported by the fact that ImpK L is required for ImpL M protein stability. Full-length ImpL M protein levels were greatly reduced along with an increase in the amount of a C-terminal truncated form in the ⌬impK L mutant (Fig. 4A) . Similar results were obtained for L. pneumophila T4SSb, in which IcmF is required to stabilize IcmH (or DotU), and the interaction of the proteins may be important in stabilization of the T4SS complex in L. pneumophila (58) . The expression of ImpL M from a heterologous lacZ promoter in the absence of ImpK L (in either A. tumefaciens or E. coli) can overcome the requirement of ImpK L for ImpL M stability but cannot restore Hcp secretion from the ⌬impK L mutant of A. tumefaciens (Fig. 4A) , suggesting that ImpK L plays an essential role in the T6SS in addition to stabilizing ImpL M. In addition, the data also suggested that ImpK L is not absolutely required for the stability of ImpL M but that interaction of ImpL M and ImpK L may be required to stabilize each protein in order to assemble a functional T6SS. We also conducted a comprehensive yeast two-hybrid analysis to determine in which cellular compartment the interaction occurs and which protein domains of ImpL M and ImpK L are important for these two proteins to interact with each other. As shown in Fig. 5A , full-length ImpK L could interact with either full-length ImpL M or N-ImpL M (residues 1 to 495 without the C-terminal periplasmic domain). N-ImpL M also interacted with both full-length ImpK L and N-ImpK L (N-terminal cytoplasmic domain, residues 1 to 255) but not with C-ImpK L (C-terminal periplasmic domain, residues 279 to 501). These data suggest that ImpL M interacts with ImpK L via the cytoplasmic N-terminal domains. Interestingly, C-ImpL M (C-terminal periplasmic domain, residues 466 to 1159) also interacted with N-ImpK L but not with C-ImpK L . Interaction of these two domains was also observed in the yeast two-hybrid system by Zheng and Leung (74) , who found that the N terminus of EvpN (an ortholog of ImpK L ) interacted with the C terminus of EvpO (an ImpL M ortholog) from E. tarda (74) . However, we did not find any interaction between C-ImpL M and full-length ImpK L using yeast two-hybrid assays (Fig. 5A ) and E. coli coexpression experiments in which hemagglutinintagged ImpK L did not copurify with C-ImpL M -His (data not shown). Therefore, the interaction between N-ImpK L and CImpL M observed in yeast may not occur in A. tumefaciens where the intact proteins are expressed. Indeed, these two domains likely do not interact in A. tumefaciens because they are not localized in the same compartment ( Fig. 2 and Fig. 4) . The self-interaction of C-ImpL M detected by yeast two-hybrid assays (Fig. 5 ) also suggested that there is oligomerization of ImpL M , a biochemical property similar to the self-oligomerization or hexamer formation of several ATPases, such as ClpV (6), VirB11 (55, 73) , and VirB4 (12), all of which are energizers of the T6SS and T4SS.
During the course of the yeast two-hybrid assays, we found that all interactions of pairs occur only in one direction (see Table S1 in the supplemental material). Because many factors can determine the outcomes of these assays (e.g., protein stability and structural constraints), we are not surprised that certain fusion proteins may be unstable or expressed in a form that does not permit interaction. Nevertheless, our proteinprotein interaction studies, along with the topology data, strongly suggest that ImpL M may self-oligomerize via its Cterminal periplasmic domain and interact with ImpK L via the N-terminal domains of the proteins facing the cytoplasm. Further resolution of the crystal structure of the ImpL M -ImpK L interaction complex in combination with mutational analysis should unravel the interaction sites and the importance of the ImpL M -ImpK L interaction in the function of the T6SS.
We also obtained genetic evidence that the Walker A motif of the IcmF family protein is important in T6SS-mediated Hcp secretion (Fig. 3) . The conserved Lys residue (K145) in the Walker A motif of ImpL M is important for T6SS-mediated Hcp secretion from A. tumefaciens because the ImpL M K145A mutant protein resulted in a significant reduction in Hcp secretion (Fig. 3B) . The T2SS ATPase XpsE of Xanthomonas campestris with substitution of Met for Lys (K331M) (60) and SecA2 of Mycobacterium tuberculosis with substitution of Ala for Lys (K115A) (29) resulted in reductions in but not loss of ATP-binding and ATPase activities. Mutation of the R64 PilQ ATPase by substitution of Gln for Lys (K238Q) resulted in a significant decrease in the ATPase activity and function in R64 thin pilus biogenesis (54) . In the case of R388 TrwD, a T4SS VirB11 family ATPase, substitution of Gln for Lys (K203Q) resulted in undetectable ATPase activity and loss of function in conjugation (53) . Thus, the defects of ImpL M K145A for mediating Hcp secretion may be caused by a reduction in its NTPbinding and hydrolysis activity. The complete loss of Hcp secretion from the ImpL M G144A K145A double mutant suggests that G144 and K145 are essential for the function of ImpL M . In the future, it would be interesting to determine the correlation between the NTP-binding and hydrolysis activities of ImpL M K145A and ImpL M G144A K145A and their effects on mediation of Hcp secretion. Interestingly, an intact Walker A motif is important for ImpL M stability because of the absence of ImpL M ⌬Walker A when the protein is expressed in a ⌬impL M mutant.
Our results are consistent with the findings for L. pneumophila T4SSb, in which substitution of Ser for Gly 38 (G38S) or substitution of Ala for Lys 39 (K39A) in the Walker A motif of IcmF resulted in attenuated replication in macrophages (75) . In contrast, in E. tarda, replacing one or two conserved amino acids (G118A, G123A, K124A, G118A G123A, or K124A S125A) in the Walker A motif of EvpO (IcmF) had no effect on T6SS substrate secretion (74) , suggesting that this NTPbinding motif does not play an important role in the E. tarda T6SS. The difference between the importance of the IcmF Walker A motif in the T6SS of A. tumefaciens and the importance of the IcmF Walker A motif in the T6SS E. tarda is intriguing and may be explainable. First, the ClpV-like AAA ϩ ATPase, another conserved T6SS ATPase found in P. aeruginosa (41) and V. cholerae (6) , may be sufficient to provide energy to mediate Hcp secretion from E. tarda but not Hcp secretion from A. tumefaciens. Alternatively, there may be another so-far-unidentified IcmF ortholog(s) encoded by the E. tarda genome which could not fully replace the function of the entire EvpO protein but may compensate for its NTP-binding activity. Nevertheless, our mutant studies provide strong genetic evidence that ImpL M may bind and/or hydrolyze NTP in mediating Hcp secretion. Exactly how ImpL M and another putative ATPase, ImpO H (ClpV-like AAA ϩ ATPase), provide the energy or conformation change that facilitates assembly of the T6SS machinery and/or substrate translocation across membranes remains to be elucidated. ClpV was recently demonstrated to have an unexpected role in protein secretion involving remodeling of VipA/VipB tubules in T6SS of V. cholerae (6) . Because ClpV interacts with VipA and VipB, the T6SS components essential for Hcp and VgrG secretion, but not with the secreted proteins Hcp and VgrG (6), one could argue that ClpV may regulate the assembly of the T6SS. It would be of great interest to determine whether IcmF provides energy to direct the secretion of Hcp, VgrG, or another substrate(s) yet to be determined.
Despite the conservation of T6SS in pathogenic Proteobacteria and its involvement in the virulence of several human and animal pathogens (14, 19, 41, 48, 56, 63, 74) , the importance of T6SS in infection by or the virulence of plant-associated bacteria is still obscure (5, 37, 39, 72) . In A. tumefaciens, deletion of hcp resulted in reduced efficiency of tumorigenesis. However, no effects on virulence were observed in Hcp secretiondeficient mutants with icmF or the entire t6ss/imp operon de- VOL. 191, 2009 IcmF IN AGROBACTERIUM T6SS 4327 leted (72) . It would be interesting to determine the role of T6SS in Agrobacterium infection by testing the mutants in different host plants and employing infection assays mimicking the natural environment. With such assays, various impL M mutants with defects in Hcp secretion and NTP-binding and hydrolysis activity may be further tested to determine their roles during the course of Agrobacterium-plant interactions.
In conclusion, ImpL M and ImpK L are two integral inner membrane proteins which interact with each other, likely via their N-terminal cytoplasmic domains. The nucleotide-binding Walker A motif located in the cytoplasmic domain of ImpL M is important for mediating Hcp secretion from A. tumefaciens. The inner membrane localization of the ImpL M -ImpK L complex may provide a scaffold for linking the T6SS cytoplasmic and outer membrane components through the peptidoglycan layer to build a TM protein channel for substrate translocation.
